While FOXO3a was detected at considerably higher levels in the cytosolic fractions compared with the nuclear fractions in all doxorubicin sensitive breast cancer, FOXO3a expression was found at appreciably higher levels in the nuclear fractions in the doxorubicin resistant breast cancer cells MCF-7DoxR and MDA-MB-231. Here, FOXO3 is linked to breast carcinoma.